Nurofen Pre Deti Active (Ibuprofen)

Ibuprofen, the active ingredient in Nurofen Pre Deti Active, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as a pediatric oral suspension for oral use. It is used to relieve pain and reduce fever in children. GNH USA supplies Nurofen Pre Deti Active as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Nurofen Pre Deti Active as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ibuprofen acts on inflammatory pathways to provide analgesic and antipyretic effects in pediatric patients.

- Fever: helps lower elevated body temperature in children. - Mild to moderate pain: eases discomfort from teething, earache or minor injuries. - Inflammatory conditions: reduces inflammation associated with minor musculoskeletal strains in young patients.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Stomach upset - Nausea - Diarrhea - Headache - Dizziness

Serious or Rare Side Effects: - Gastrointestinal bleeding - Severe allergic reaction (anaphylaxis) - Liver enzyme elevation - Kidney function impairment - Stevens‑Johnson syndrome

When using ibuprofen‑containing products, certain precautions help ensure safe use.

- Assess risk of gastrointestinal bleeding: evaluate patient history for ulcers. - Monitor renal function: especially in dehydrated or elderly patients. - Avoid use in late pregnancy (> 28 weeks): risk of premature duct closure. - Do not combine with other NSAIDs: increases risk of adverse effects. - Store at ambient temperature: keep in the original pack and protect from moisture.

Ibuprofen may interact with several medicines, altering effectiveness or increasing risk of side effects.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin) – heightened bleeding risk. - High‑dose aspirin – increased gastrointestinal toxicity. - Selective COX‑2 inhibitors – additive renal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors (e.g., enalapril) – possible reduction in antihy pediatric  yield  g . - Diuretics – may enhance renal function decline. - Lithium – increased lithium levels. - Methotrexate – reduced renal clearance, raising toxicity. - SSRIs (e.g., fluoxetine) – higher risk of GI bleeding.